• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多糖在结肠靶向给药中的当前应用。

Current applications of polysaccharides in colon targeting.

作者信息

Hovgaard L, Brøndsted H

机构信息

Royal Danish School of Pharmacy, Department of Pharmaceutics, Universitetsparken, Copenhagen ø, Denmark.

出版信息

Crit Rev Ther Drug Carrier Syst. 1996;13(3-4):185-223. doi: 10.1615/critrevtherdrugcarriersyst.v13.i3-4.10.

DOI:10.1615/critrevtherdrugcarriersyst.v13.i3-4.10
PMID:9016381
Abstract

Polysaccharides have over the years been used widely in pharmaceutical, chemical, and biochemical drug delivery. This family of natural polymers has an appeal to the area of drug delivery as it is comprised of polymers with a large number of derivatizable groups, a wide range of molecular weights, varying chemical compositions, and for the most part, a low toxicity and biodegradability, yet a high stability. The main scope of this review is to relate the polysaccharides available now to the rapidly growing field of colonic drug delivery. Polysaccharides have been applied to the area as controlled release coatings, matrices, macromolecular carriers, and biodegradable carriers. Bacterial sources of polysaccharidases as well as a detailed treatise of the enzymatic flora of the colonic region are discussed, followed by a presentation of the polysaccharides available for the purpose of colon-specific drug delivery. A final overview of the various approaches to obtain colon-specific delivery by using polysaccharides and a summary of available in vitro and in vivo testing methods will lead to the conclusion that polysaccharides at this point appear to be very promising compounds for use in obtaining colon-specific drug delivery systems.

摘要

多年来,多糖已广泛应用于制药、化学和生化药物递送领域。这类天然聚合物在药物递送领域具有吸引力,因为它由具有大量可衍生化基团、广泛分子量范围、不同化学组成的聚合物组成,并且在大多数情况下,毒性低、可生物降解,但稳定性高。本综述的主要范围是将现有的多糖与快速发展的结肠药物递送领域联系起来。多糖已被应用于控释包衣、基质、大分子载体和可生物降解载体等领域。讨论了多糖酶的细菌来源以及结肠区域酶菌群的详细论述,随后介绍了可用于结肠特异性药物递送目的的多糖。最后概述了利用多糖实现结肠特异性递送的各种方法以及现有体外和体内测试方法的总结,将得出结论:此时多糖似乎是用于获得结肠特异性药物递送系统的非常有前景的化合物。

相似文献

1
Current applications of polysaccharides in colon targeting.多糖在结肠靶向给药中的当前应用。
Crit Rev Ther Drug Carrier Syst. 1996;13(3-4):185-223. doi: 10.1615/critrevtherdrugcarriersyst.v13.i3-4.10.
2
Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon.可生物降解天然多糖用于结肠靶向给药的研究进展
J Pharm Pharm Sci. 2007;10(1):86-128.
3
Polysaccharides for colon targeted drug delivery.用于结肠靶向给药的多糖。
Drug Deliv. 2004 Mar-Apr;11(2):129-48. doi: 10.1080/10717540490280778.
4
Pharmaceutical approaches to colon targeted drug delivery systems.结肠靶向给药系统的药物学方法。
J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66.
5
Polysaccharides: a targeting strategy for colonic drug delivery.多糖:结肠递药的靶向策略。
Expert Opin Drug Deliv. 2011 Jun;8(6):779-96. doi: 10.1517/17425247.2011.574121. Epub 2011 Apr 21.
6
Approaches and opportunities in colon-specific drug delivery.结肠特异性药物递送的方法与机遇
Crit Rev Ther Drug Carrier Syst. 1995;12(2-3):101-49. doi: 10.1615/critrevtherdrugcarriersyst.v12.i2-3.10.
7
Novel prospective in colon specific drug delivery system.结肠特异性给药系统的新前景。
Polim Med. 2014 Apr-Jun;44(2):109-18.
8
Polysaccharides in colon-specific drug delivery.结肠靶向给药中的多糖。
Int J Pharm. 2001 Aug 14;224(1-2):19-38. doi: 10.1016/s0378-5173(01)00720-7.
9
Advances in colonic drug delivery.结肠给药的进展。
Drugs. 2005;65(14):1991-2007. doi: 10.2165/00003495-200565140-00006.
10
Azo compounds in colon-specific drug delivery.结肠特异性药物递送中的偶氮化合物。
Expert Opin Drug Deliv. 2007 Sep;4(5):547-60. doi: 10.1517/17425247.4.5.547.

引用本文的文献

1
Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis.靶向炎症递送尿石素 A 可减轻化学和免疫检查点抑制剂诱导的结肠炎。
J Nanobiotechnology. 2024 Nov 13;22(1):701. doi: 10.1186/s12951-024-02990-8.
2
Elucidating structure-property relationships of guar gum biomolecules: insights from -polynomial and QSPR modeling.阐明瓜尔胶生物分子的结构-性质关系:来自多项式和定量构效关系建模的见解。
Front Chem. 2024 Jul 9;12:1410876. doi: 10.3389/fchem.2024.1410876. eCollection 2024.
3
Impact of gastric and bowel surgery on gastrointestinal drug delivery.
胃和肠手术对胃肠道药物输送的影响。
Drug Deliv Transl Res. 2023 Jan;13(1):37-53. doi: 10.1007/s13346-022-01179-6. Epub 2022 May 18.
4
Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors.用于胃肠道区域靶向的口服药物递送进展——生理、病理生理和药学因素的影响
Front Pharmacol. 2020 Apr 28;11:524. doi: 10.3389/fphar.2020.00524. eCollection 2020.
5
A novel dissolution media for testing drug release from a nanostructured polysaccharide-based colon specific drug delivery system: an approach to alternative colon media.一种用于测试基于纳米结构多糖的结肠特异性药物递送系统药物释放的新型溶出介质:替代结肠介质的方法。
Int J Nanomedicine. 2016 Mar 17;11:1089-95. doi: 10.2147/IJN.S97177. eCollection 2016.
6
Insight to drug delivery aspects for colorectal cancer.结直肠癌药物递送方面的见解。
World J Gastroenterol. 2016 Jan 14;22(2):582-99. doi: 10.3748/wjg.v22.i2.582.
7
A nanomedicine-promising approach to provide an appropriate colon-targeted drug delivery system for 5-fluorouracil.一种有望为5-氟尿嘧啶提供合适的结肠靶向给药系统的纳米医学方法。
Int J Nanomedicine. 2015 Nov 23;10:7175-82. doi: 10.2147/IJN.S89030. eCollection 2015.
8
Assessment of Immunotoxicity of Dextran Coated Ferrite Nanoparticles in Albino Mice.葡聚糖包被的铁氧体纳米颗粒对白化小鼠免疫毒性的评估
Mol Biol Int. 2015;2015:518527. doi: 10.1155/2015/518527. Epub 2015 Oct 20.
9
Determination of oxidative stress related toxicity on repeated dermal exposure of hydroxyapatite nanoparticles in rats.大鼠反复经皮暴露于羟基磷灰石纳米颗粒后氧化应激相关毒性的测定。
Int J Biomater. 2014;2014:476942. doi: 10.1155/2014/476942. Epub 2014 Dec 21.
10
Preparation and In vitro Investigation of Chitosan Compressed Tablets for Colon Targeting.用于结肠靶向的壳聚糖压制片的制备及体外研究
Adv Pharm Bull. 2011;1(2):87-92. doi: 10.5681/apb.2011.013. Epub 2011 Dec 15.